|
CZ285762B6
(cs)
|
1993-06-10 |
1999-11-17 |
Eli Lilly And Company |
Farmaceutický prostředek vhodný pro prevenci dávení a zvracení a pro ošetřování sexuální dysfunkce savců a jeho použití
|
|
KR100197892B1
(ko)
|
1994-09-09 |
1999-06-15 |
남창우 |
신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법
|
|
KR0173862B1
(ko)
|
1995-02-11 |
1999-04-01 |
조규향 |
O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
|
|
US5756817C1
(en)
|
1995-02-11 |
2001-04-17 |
Sk Corp |
O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same
|
|
IT1275903B1
(it)
|
1995-03-14 |
1997-10-24 |
Boehringer Ingelheim Italia |
Esteri e ammidi della 1,4-piperidina disostituita
|
|
KR0173863B1
(ko)
|
1995-04-10 |
1999-04-01 |
조규향 |
페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
|
|
CA2240060C
(en)
|
1996-10-10 |
2007-07-17 |
Sk Corporation |
O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same
|
|
AU4674797A
(en)
|
1996-10-22 |
1998-05-15 |
Ortho Pharmaceutical Corporation |
Phenylalaninol derivatives for the treatment of central nervous system disorders
|
|
TW402591B
(en)
|
1997-07-11 |
2000-08-21 |
Janssen Pharmaceutica Nv |
Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
|
|
ES2234248T3
(es)
|
1998-04-28 |
2005-06-16 |
Dainippon Pharmaceutical Co., Ltd. |
Derivados de 1-(1-sustituido-4-piperidinil) metil)-4-piperidina, procedimiento de produccion de estos; composiciones medicinales que contienen estos compuestos e intermediarios de estos compuestos.
|
|
US20010029262A1
(en)
|
1998-06-29 |
2001-10-11 |
Sethi Kapil Dev |
Method of treatment or prophylaxis
|
|
TW518218B
(en)
|
1999-05-27 |
2003-01-21 |
Merck Patent Gmbh |
Pharmaceutical compositions comprising 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine or its physiologically acceptable salts for use in the treatment of sub-type anxiety disorders
|
|
US20010034320A1
(en)
|
2000-01-18 |
2001-10-25 |
Hans-Michael Brecht |
NK1-receptor antagonists for treating restless legs syndrome
|
|
CA2433018A1
(en)
|
2000-12-21 |
2002-06-27 |
Joel C. Barrish |
Thiazolyl inhibitors of tec family tyrosine kinases
|
|
NZ551954A
(en)
|
2001-02-27 |
2008-07-31 |
Ortho Mcneil Pharm Inc |
Carbamate compounds for use in preventing or treating movement disorders
|
|
WO2002067922A1
(en)
|
2001-02-27 |
2002-09-06 |
Ortho-Mcneil Pharmaceutical, Inc. |
Carbamate compounds for use in the treatment of pain
|
|
WO2002080928A1
(en)
|
2001-04-03 |
2002-10-17 |
Merck & Co., Inc. |
N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
|
|
CA2449249A1
(en)
|
2001-06-12 |
2002-12-19 |
Merck & Co., Inc. |
Nr2b receptor antagonists for the treatment or prevention of migraines
|
|
US20040115263A1
(en)
|
2002-08-26 |
2004-06-17 |
Robertson David W. |
Use of bupropion for treating restless legs syndrome
|
|
JP2006502180A
(ja)
|
2002-09-20 |
2006-01-19 |
ファイザー株式会社 |
５−ｈｔ４レセプターモジュレーターとしてのｎ−置換されたピペリジニル−イミダゾピリジン化合物
|
|
WO2004094418A1
(en)
|
2003-04-21 |
2004-11-04 |
Pfizer Inc. |
Imidazopyridine compounds having 5-ht4 receptor agonistic activity and 5-ht3 receptor antagonistic activity
|
|
PL1664036T3
(pl)
|
2003-09-03 |
2012-04-30 |
Pfizer |
Związki benzimidazolonu wykazujące działanie agonistyczne względem receptora 5-ht4
|
|
US20050080268A1
(en)
|
2003-10-08 |
2005-04-14 |
Yong-Moon Choi |
Process of preparing O-carbamoyl compounds in the presence of active amine group
|
|
EP1548011A1
(en)
|
2003-12-23 |
2005-06-29 |
Neuro3D |
Benzo[1,4]diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof
|
|
WO2005092882A1
(en)
|
2004-03-01 |
2005-10-06 |
Pfizer Japan, Inc. |
4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders
|
|
AU2005302589B2
(en)
|
2004-10-28 |
2010-09-16 |
Sk Biopharmaceuticals Co., Ltd. |
Adjunctive therapy for depression
|
|
DK1869019T3
(da)
|
2005-04-08 |
2014-10-06 |
Pfizer Prod Inc |
Bicycliske [3.1.0]heteroarylamider som glycintransportinhibitorer type I
|
|
US7598279B2
(en)
|
2005-04-22 |
2009-10-06 |
Sk Holdings Co., Ltd. |
Neurotherapeutic azole compounds
|
|
EP1890684B1
(en)
|
2005-06-08 |
2013-08-14 |
SK Biopharmaceuticals Co., Ltd. |
Treatment of sleep-wake disorders
|
|
EP1893291B1
(en)
|
2005-06-22 |
2010-03-03 |
SK Holdings Co., Ltd. |
Treatment of sexual dysfunction
|
|
EP1928451B1
(en)
|
2005-07-26 |
2011-12-28 |
SK Biopharmaceuticals Co., LTD |
Methods for treating substance-related disorders
|
|
EP1754476A1
(en)
|
2005-08-18 |
2007-02-21 |
Schwarz Pharma Ag |
Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
|
|
EA200970377A1
(ru)
|
2006-10-13 |
2009-10-30 |
Янссен Фармацевтика Нв |
Композиции фенилалкиламинокарбамата
|
|
HUP0700370A2
(en)
*
|
2007-05-24 |
2009-04-28 |
Richter Gedeon Nyrt |
Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
|
|
US8642772B2
(en)
|
2008-10-14 |
2014-02-04 |
Sk Biopharmaceuticals Co., Ltd. |
Piperidine compounds, pharmaceutical composition comprising the same and its use
|
|
KR102173587B1
(ko)
|
2009-06-22 |
2020-11-04 |
에스케이바이오팜 주식회사 |
피로의 치료 또는 예방 방법
|
|
US8232315B2
(en)
|
2009-06-26 |
2012-07-31 |
Sk Biopharmaceuticals Co., Ltd. |
Methods for treating drug addiction and improving addiction-related behavior
|
|
KR101097605B1
(ko)
|
2009-11-04 |
2011-12-22 |
알.에프 에이치아이씨 주식회사 |
도허티 증폭기
|
|
US8895609B2
(en)
|
2009-11-06 |
2014-11-25 |
Sk Biopharmaceuticals Co., Ltd. |
Methods for treating attention-deficit/hyperactivity disorder
|
|
KR101783633B1
(ko)
|
2009-11-06 |
2017-10-10 |
에스케이바이오팜 주식회사 |
섬유근육통 증후군의 치료 방법
|
|
US8623913B2
(en)
|
2010-06-30 |
2014-01-07 |
Sk Biopharmaceuticals Co., Ltd. |
Methods for treating restless legs syndrome
|
